Expression of the PLS3 Gene in Circulating Cells in Patients with Colorectal Cancer

Journal Title: Polish Journal of Surgery - Year 2015, Vol 87, Issue 2

Abstract

Circulating tumor cells (CTC) are cells in circulating blood that have the antigen and gene features of tumor cells of a specific type. Since they can be potentially used in diagnostics and monitoring of treatment of many tumors, they have been attracting attention of researchers worldwide. Plastin-3 (PLS3) is one of such markers of CTC. The aim of the study was to assess expression of PLS3 in CTC in patients with colorectal cancer, to conduct a statistical analysis and to demonstrate a link between expression of PLS3 and progress of the disease, level of CEA and Ca19-9 markers, gender and age of the patients. Material and methods. A group of 85 patients of the Department of General and Colorectal Surgery of the Medical University in Łódź were enrolled in this study. Circulating tumor cells were isolated from whole blood of patients with colorectal cancer and an analysis of PLS3 gene expression in CTC was conducted. The next step was to conduct a statistical analysis and to demonstrate a link between expression of PLS3 in patients’ CTC and progress of the disease, level of CEA and Ca19-9 markers, gender and age of the patients. Results. PLS3 is a marker which can be potentially used in prediction and monitoring of colorectal cancer. A link between expression of PLS3 in CTC of patients with colorectal cancer and metastasis to lymph nodes has been demonstrated. It may be of key importance how PLS3 could impact the qualification to supplementary cancer treatment in patients with stage II colorectal cancer. A link between expression of PLS3 gene in CTC and gender requires further in-depth studies. It is beyond doubt that PLS3 must be further investigated to determine its role in diagnostics, prediction, treatment and monitoring of treatment of colorectal cancer.

Authors and Affiliations

Ryszard Kujawski, Karolina Przybyłowska-Sygut, Michał Mik, Miłosz Lewandowski, Radzisław Trzciński, Maciej Berut, Łukasz Dziki, Ireneusz Majsterek, Adam Dziki

Keywords

Related Articles

Chirurgiczne leczenie raka trzustki

Jedynym sposobem dającym możliwość wyleczenia chorego na gruczolakoraka trzustki (RT) jest chirurgiczne wycięcie nowotworu. Za standardowe leczenie chirurgiczne resekcyjnego raka głowy trzustki uważa się klasyczną pankre...

Bleeding liver tumor in a patient on anticoagulation therapy – case report

Intraabdominal bleeding is a serious surgical problem, particularly in elderly patients following an anticoagulant therapy. It occurs, that abdominal haemorrhage is the first symptom of hepatocellular carcinoma, mostly i...

Satisfaction with life and disease acceptance by patients with a stomy related to surgical treatment of the rectal cancer – determinants of quality of life?

Satisfaction with life and disease acceptance by patients with a stomy related to surgical treatment of the rectal cancer depend on multiple factors. Such factors as social support, life conditions and time that elapsed...

Wyniki rekonstrukcji muszli małżowiny usznej wyspowym płatem z okolicy zamałżowinowej u pacjentów po wycięciu raka

Celem pracy było przedstawienie naszego doświadczenia z zastosowania wyspowego płata zamałżowinowego (pif) do rekonstrukcji muszli małżowiny usznej oraz kliniczna analiza wyników operacji tą metodą u pacjentów po wycięci...

Download PDF file
  • EP ID EP74454
  • DOI 10.1515/pjs-2015-0020
  • Views 104
  • Downloads 0

How To Cite

Ryszard Kujawski, Karolina Przybyłowska-Sygut, Michał Mik, Miłosz Lewandowski, Radzisław Trzciński, Maciej Berut, Łukasz Dziki, Ireneusz Majsterek, Adam Dziki (2015). Expression of the PLS3 Gene in Circulating Cells in Patients with Colorectal Cancer. Polish Journal of Surgery, 87(2), 59-64. https://europub.co.uk/articles/-A-74454